Catalyst Pharmaceuticals Inc (CPRX)

Return on assets (ROA)

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net income	US$ in thousands	163,889	71,410	83,079	39,482	74,983
Total assets	US$ in thousands	851,411	470,114	375,630	237,788	192,354
ROA		19.25%	15.19%	22.12%	16.60%	38.98%

December 31, 2024 calculation

ROA = Net income ÷ Total assets
= $163,889K ÷ $851,411K
= 19.25%

The return on assets (ROA) for Catalyst Pharmaceuticals Inc has shown some fluctuations over the years. In 2020, the ROA was notably high at 38.98%, indicating that the company generated significant profit relative to its total assets. However, there was a decline in ROA to 16.60% in 2021, suggesting a decrease in efficiency in generating earnings from its assets.

Subsequently, in 2022, the ROA improved to 22.12%, reflecting a better performance in utilizing its assets to generate profits. However, there was a slight dip in 2023 with an ROA of 15.19%, indicating a decrease in profitability relative to the assets employed.

In the most recent year, 2024, the ROA increased to 19.25%, showing an improvement in the company's ability to generate earnings from its assets compared to the previous year. Overall, while there have been fluctuations in ROA, Catalyst Pharmaceuticals Inc has demonstrated varying levels of efficiency in utilizing its assets to generate profits over the years.